WEST PHARMACEUTICAL SERVICES INC Quarterly Nonoperating Income (Expense) in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
West Pharmaceutical Services Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q3 2024.
  • West Pharmaceutical Services Inc Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $3.2M, a 67% decline year-over-year.
  • West Pharmaceutical Services Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $17.6M, a 28.5% increase year-over-year.
  • West Pharmaceutical Services Inc annual Nonoperating Income (Expense) for 2023 was $22M.
  • West Pharmaceutical Services Inc annual Nonoperating Income (Expense) for 2022 was -$54.1M, a 1491% decline from 2021.
  • West Pharmaceutical Services Inc annual Nonoperating Income (Expense) for 2021 was -$3.4M, a 39.3% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $17.6M $3.2M -$6.5M -67% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-24
Q2 2024 $24.1M $2.5M +$100K +4.17% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-25
Q1 2024 $24M $4.6M +$2M +76.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $22M $7.3M +$8.3M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $13.7M $9.7M +$59.7M Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-24
Q2 2023 -$46M $2.4M +$3.6M Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-25
Q1 2023 -$49.6M $2.6M +$4.5M Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 -$54.1M -$1M +$1.1M +52.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 -$55.2M -$50M -$49.7M -16567% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 -$5.5M -$1.2M -$900K -300% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 -$4.6M -$1.9M -$1.2M -171% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q4 2021 -$3.4M -$2.1M +$1.9M +47.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 -$5.3M -$300K +$1.2M +80% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 -$6.5M -$300K +$1.3M +81.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-28
Q1 2021 -$7.8M -$700K -$2.2M -147% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 -$5.6M -$4M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 -$1.5M Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 -$1.6M Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $1.5M Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.